Kidney transplants in African Americans and non-African Americans: Equivalent outcomes with living but not deceased donors

Transplantation Proceedings

Volumn 37, Issue 2, 2005, Pages 699-700

  Light, J A ^a   Barhyte, D Y ^a   Lahman, L ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; HUMAN; KAPLAN MEIER METHOD; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LAPAROSCOPY; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 17844377965     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.11.025     Document Type: Conference Paper

References (3)

1. J.F. Neylan Immunosuppressive therapy in high-risk transplant patients: dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients. US Renal Transplant Mycophenolate Mofetil Study Group Transplantation 64 1997 1277
2. R. Pollak, R.L. Wong, C.T. Chang Cyclosporine bioavailability of Neoral and Sandimmune in white and black de novo renal transplant recipients. Neoral Study Group Ther Drug Monit 21 1999 661
3. T.M. Sasaki, F. Finelli, E. Bugarin Is laparoscopic donor nephrectomy the new criterion standard? Arch Surg 135 2000 943